Although the phenotype of tumor-infiltrating NK cells upon dual CD73/CD155 treatment was comparable to that of NK cells treated with CD155 alone, dual-treated tumors showed a significantly larger proportion of NK cells infiltrating the tumors and a more robust anti-tumor response, indicating that phenotype alone does not define NK cell dysfunction. Here, PVR is linked to neoplasm.